Clinical trial Recruiting at 1 site Interventional Ages 18 to 70 Women only

Single versus double drains after modified radical mastectomy with quilting stitches

Official title: Comparative Analysis of Quilting Sutures With a Single Axillary Drain Versus Double Drains in the Axillary and Pectoral Regions for the Prevention of Seroma After Modified Radical Mastectomy

Run by Sindh Institute of Urology and Transplantation · NCT07512141 · Data updated 2026-11-12

This trial will test whether using one drain instead of two, together with quilting stitches, reduces fluid buildup, pain, and infections after modified radical mastectomy for adults with breast cancer.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexWomen only
Enrollment60 (estimated)
SponsorSindh Institute of Urology and Transplantation
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Karachi, Sindh)
StatusRecruiting
StartedMarch 27, 2026
Main results expectedMarch 31, 2027
Study endsMarch 31, 2027
Registry record updatedApril 6, 2026
Trial IDNCT07512141 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–69 with diagnosed breast carcinoma who are scheduled for upfront or post-neoadjuvant modified radical mastectomy are the intended participants.

Probably not a fit

Patients having mastectomy with sentinel lymph node biopsy, immediate breast reconstruction, or flap coverage are excluded and would not be eligible to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients undergoing modified radical mastectomy will all receive flap quilting (suturing the skin flaps to the pectoralis muscle) and standard skin closure performed by experienced breast surgeons. Participants are randomly assigned to receive either two drains (pectoral and axillary) or a single axillary drain, with a 20 Fr JP drain used in both groups. Outcomes recorded include seroma formation, drain output and duration, pain by Visual Analogue Scale, and surgical site infection, with follow-up on postoperative days 1–30 and at routine clinic visits including day 7 and day 14. Informed consent is obtained in English or Urdu and allocation is done by computer-based randomisation to minimise bias.

Why it matters

Potential benefit: If successful, patients may experience less fluid collection, shorter drain times, less pain, and fewer wound infections after surgery.

How similar studies have gone: Previous research has shown that quilting stitches can reduce seroma formation, but direct comparisons of one versus two drains after quilting have been less commonly reported.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients older than 18 years but less than 70 years of age,
* Diagnosed with breast carcinoma.
* All the patients undergoing upfront MRM,
* All patients undergoing MRM post-neoadjuvant chemotherapy.

Exclusion Criteria:

* Mastectomy \& sentinel lymph node biopsy
* Breast reconstruction surgery
* Defect covering flaps

Where it's running

  • Sindh Institute of Urology and Transplantation
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Bushra Shirazi, FCPS — Sindh Institute of Urology and Transplantation
  • Study coordinator: Syed Abbas, FCPS
  • Email: smabbas69@hotmail.com
  • Phone: +923331318838

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.